Key result
Persistent LBBB developed in 27.4% of patients after CoreValve TAVI and showed no effect on 1-year mortality or heart failure hospitalization, but increased short-term pacemaker implantation.
Why the study?
Does persistent LBBB after TAVI increase mortality or heart failure hospitalization in patients with severe aortic stenosis?
Cohort (n=818)
Yes
Does persistent LBBB after TAVI increase mortality or heart failure hospitalization in patients with severe aortic stenosis?
Answers are grounded in this paper and cite their sources.
Persistent LBBB after CoreValve TAVI does not worsen 1-year outcomes; leaves open questions on long-term conduction risks and optimal device selection.
BACKGROUND: Conduction disturbances are relatively common after transcatheter aortic valve implantation. Previous data demonstrated an adverse impact of persistent left bundle-branch block (LBBB) after surgical aortic valve replacement. It is unclear whether new-onset LBBB may also impact the prognosis of patients after transcatheter aortic valve implantation. METHODS AND RESULTS: Among 1060 patients treated with a CoreValve Revalving System transcatheter aortic valve implantation between October 2007 and April 2011 in high-volume centers in Italy, we analyzed those without LBBB or pacemaker at admission (879 patients [82.9%]). We further excluded those who underwent permanent pacemaker implantation within 48 hours after the procedure (61 patients [7%]), for a final study population of 818 patients. Among them, 224 patients (group A; 27.4%) developed a persistent LBBB and the remaining 594 (group B; 72.6%) did not. Clinical characteristics were similar between groups. A low implantation was significantly more frequent in group A (15% versus 9.8%, P=0.02). No patients were censored before 1 year (median follow-up period 438 days, interquartile range 174-798 days). Survival analyses and inherent log-rank tests showed that LBBB was not associated with higher all-cause mortality, cardiac mortality, or hospitalization for heart failure at 30 days or 1 year. At 30 days, but not at 1 year, group A had a significantly higher rate of pacemaker implantation. CONCLUSIONS: In this registry of high-volume centers, persistent LBBB after CoreValve Revalving System transcatheter aortic valve implantation showed no effect on hard end points. On the other hand, LBBB was associated with a higher short-term rate of pacemaker implantation.
No takes yet. Share an insight, caveat, or question.
Testa et al. (2013) conducted a cohort in Transcatheter aortic valve implantation (n=818). Persistent left bundle-branch block (LBBB) vs. No persistent LBBB was evaluated on All-cause mortality, cardiac mortality, or hospitalization for heart failure at 30 days or 1 year. Persistent LBBB developed in 27.4% of patients after CoreValve TAVI and showed no effect on 1-year mortality or heart failure hospitalization, but increased short-term pacemaker implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: